CLB 2019 Proxy Statement

Grants of Plan-Based Awards Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards Table Outstanding Equity Awards at Fiscal Year End Exercises and Stock Vested Post-Employment Benefit Plans Nonqualified Deferred Compensation Plan Potential Payments Upon Termination or Change in Control Employment Agreements COMPENSATION COMMITTEE REPORT AUDIT COMMITTEE REPORT INFORMATION ABOUT OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Audit Fee Summary AGENDA ITEMS Item 1. Election of Class II Supervisory Directors Item 2. Appointment of KPMG as our Independent Registered Public Accounting Firm for 2019 Item 3. Confirmation and Adoption of Annual Accounts Item 4. Cancellation of Our Repurchased Shares Held at 12:01 A.M. CEST On May 23, 2019 Item 5. Extension and Renewal of Existing Authority to Repurchase Shares Item 6. Extension of Authority to Issue Shares of Core Laboratories N.V. until November 23, 2020 Item 7. Extension of Authority of Supervisory Board to Limit or Eliminate Preemptive Rights until November 23, 2020 Item 8. To Approve, On an Advisory Basis, the Compensation of our Named Executive Officers as Described in the CD&A Section of this Proxy Statement Item 9. Other Matters to Be Voted on OTHER PROXY MATTERS Information About Our 2020 Annual Meeting: Shareholder Proposals and Shareholder Access The Right of Shareholders to Request a Shareholder Meeting Shareholders Sharing the Same Address Incorporation by Reference Other Information PROXY CARD 36 37 38 39 39 41 41 42 48 49 51 51 53 53 53 54 54 54 55 56 57 57 58 58 58 58 59 59 60